Asset Management One
KYNB

Asset Management One’s Kyntra Bio KYNB Stock Holding History

Asset Management One’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-5,706
Closed -$2.91M – 1065
2016
Q3 		$2.91M Sell
5,706
-1,043
-15% -$491K 0.04% 483
2016
Q2 		$2.77M Sell
6,749
-439
-6% -$201K 0.04% 494
2016
Q1 		$3.71M Buy
7,188
+192
+3% +$95.7K 0.05% 397
2015
Q4 		$5.48M Buy
6,996
+734
+12% +$487K 0.08% 289
2015
Q3 		$3.39M Sell
6,262
-759
-11% -$460K 0.05% 444
2015
Q2 		$4.05M Buy
7,021
+618
+10% +$359K 0.06% 424
2015
Q1 		$5.06M Sell
6,403
-560
-8% -$434K 0.06% 385
2014
Q4 		$4.79M Buy
+6,963
New +$4.48M 0.06% 399

Other funds holding KYNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Asset Management One's KYNB Position: Q4 2016 in Review

Asset Management One sold out of Kyntra Bio (KYNB) in Q4 2016, closing a stake of 5,706 shares — an estimated $2.91M sold.

Asset Management One first reported a position in KYNB in Q4 2014 and held it in 8 quarters. The position peaked at $5.48M in Q4 2015. 140 funds tracked by Wall St. Rank hold KYNB as of Q4 2016.

  • Asset Management One reported no remaining Kyntra Bio position as of Q4 2016 after selling out during the quarter.
  • Asset Management One sold 5,706 Kyntra Bio shares in Q4 2016, an estimated $2.91M.
  • Asset Management One first reported a position in Kyntra Bio in Q4 2014 and held it in 8 quarters.
  • Asset Management One's Kyntra Bio position peaked at $5.48M in Q4 2015.
  • 140 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.